News Focus
News Focus
Post# of 257295
Next 10
Followers 7
Posts 193
Boards Moderated 0
Alias Born 10/26/2011

Re: caravon post# 149707

Monday, 10/01/2012 11:42:05 AM

Monday, October 01, 2012 11:42:05 AM

Post# of 257295

MARQUEE's much higher mKRAS population could bring the erlotinib control arm mOS to under 6 month



Much higher than which trial? ARQL's P2 trial? Or other non-squamous (2ndline?) NSCLC trials?

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today